Policy plays a critical role in the fight against cancer, influencing the funding of cancer research and driving the approval of safe and effective anticancer therapies. With the increasing complexity of cancer-related policy issues, the need for active engagement of cancer researchers in the policymaking process has never been greater.Read More
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib (Piqray), polatuzumab vedotin-piiq (Polivy), selinexor (Xpovio), and darolutamide (Nubeqa)—for treating certain patients with a wide array of cancer types. Molecularly targeted therapeutics are the cornerstone of precision oncology. So, this flurry of approvals highlights that progress in this important area of cancer care is continuing unabated.Read More
This spring, in the inaugural year of the American Association for Cancer Research (AACR) Global-Scholar-In-Training Awards (GSITA) program, 15 young researchers from around the world arrived in Atlanta eager to share their knowledge and to draw upon the global brain trust of cancer scientists attending AACR’s 110th Annual Meeting. Recipients also participated in a networking and mentoring event hosted by Emory University’s Winship Cancer Institute which included a tour of laboratory and clinical facilities, presentations by doctoral students, and research and career advice from Emory faculty and staff.Read More
Every two minutes, a woman somewhere in the world dies of cervical cancer.
That harrowing statistic, shared by Anna R. Giuliano, PhD, founding director of the Center for Immunization and Infection Research in Cancer at the Moffitt Cancer Center in Tampa, Florida, reflects a great frustration in public health. There is a vaccine that prevents infection with the virus that can cause cervical cancer and several other cancer types, yet worldwide, not enough people are taking advantage of it.Read More
Every person who hears the words “you have cancer” has a unique story. As part of Cancer Today’s mission to provide “practical hope” and “real knowledge” to those who are affected by cancer, we strive to highlight those stories to provide a real-life glimpse into the challenges of treatment and what comes after.
As National Cancer Survivor Month comes to a close, we’d like to take an opportunity to reflect on some of the lessons we’ve learned from the cancer survivors who have shared their stories with Cancer Today, the magazine and online resource for cancer patients, survivors, and caregivers, which is published by the American Association for Cancer Research.Read More
When I started my postdoc at Georgetown University’s Lombardi Comprehensive Cancer Center in May 2016, I was thrilled to experience a truly comprehensive training in breast cancer. During my tenure, I decided to take advantage of opportunities offered to me outside of the lab to learn about cancer from every angle, including attending weekly breast tumor boards and presenting my work to the Georgetown Breast Cancer Advocates (GBCA).
I’ll never forget at the end of my presentation with GBCA, one of the advocates, Jamie, asked what the side effects were for a new treatment I was proposing. I was proud that I had done some research on this and confidently stated, “they are the same as tamoxifen,” a commonly used breast cancer treatment.Read More
Decades of research have led to the identification of an increasing number of cancer-causing substances in our environment. These substances, known as environmental carcinogens, can be found anywhere, including in our air, water, food, and workplace.
Despite the progress we have made in identifying and increasing awareness of such carcinogens, experts believe that we have a long way to go before we have fully delineated them and successfully regulated our exposures to reduce cancer incidence. Therefore, establishing methods to better identify all of the carcinogens in our environment, to measure our exposure to them, and to prevent cancer caused by them are areas of active investigation in the field.Read More
In the past year, the number of American teenagers using tobacco products has increased by nearly 40 percent, reversing a trend that public health officials worked tirelessly to achieve.
The primary culprit in the resurgence of smoking? E-cigarettes. Taking aim at this growing public health problem, the American Association for Cancer Research (AACR) held a congressional briefing on Wednesday, June 12, titled “E-cigarettes and Nicotine Addiction: A Potential Health Crisis for Youth and Young Adults.” The roster of speakers included leaders from government, research, and policy sectors.
The tobacco product landscape is evolving and the AACR Tobacco Products and Cancer Subcommittee has been cognizant of the shift from combusted products (e.g., cigarettes) to alternative nicotine delivery systems, such as e-cigarettes. While it is generally accepted that e-cigarettes are safer than traditional cigarettes, these products still present risks and the AACR has been active in trying to keep children from having access to them.Read More
On Saturday, May 4, Philadelphians flooded the Benjamin Franklin Parkway for the Franklin Institute’s ninth annual Philadelphia Science Festival. For the fourth consecutive year, the American Association for Cancer Research (AACR) was a sponsor of the community event, giving eager kids and their families the opportunity to learn about science with hands-on experiments and activities.Read More